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Collateral nervous damages after cryoballoon pulmonary vein Isolation
Aurélie Guiot [Orateur], Arnaud Savoure, Bénédicte Godin, Frédéric Anselme
CHU Charles Nicolle, Cardiologie, Rouen, France
Background: Various types of complications have been reported after
atrial fibrillation (AF) ablation using radiofrequency energy but those have not
been well defined when using cryoballoon ablation technique. The objective
of this prospective study was to assess types, incidence and outcome of com-
plications after cryoballoon pulmonary venous isolation (PVI) for AF.
Methods: This prospective monocentric study included 66 FA consecutive
patients (39 males, age 57+/–11 years) who underwent cryoballoon PVI for
symptomatic paroxysmal AF. Phrenic nerve integrity was assessed by pacing
from the superior vena cava during isolation of the right PVs. Before dis-
charge, all patients were subjected to 24-hour Holter electrocardiograms,
echocardiography, and esophagogastroduodenoscopy (EGD). Cardiac MRI
was scheduled between 1 and 3 months post-procedure. At a mean follow up
of 3.7±1.7 months after ablation, patients underwent clinical review and
24 hour Holter electrocardiograms.
Results: The mean number of balloon cryoapplications was 10.0±2.1
per patient and 2.5±1.0 per vein. A 28 mm cryoballoon was used in
49 patients (74%) and a 23 mm cryoballoon in the 17 remaining patients
(26%). Nine patients experienced complications attributed to collateral
nervous damage (14%): Asymptomatic gastroparesis was observed in 6 pts
(9%), transient phrenic nerve palsy (PNP) in 5 (8%), and symptomatic
inappropriate sinus tachycardia requiring beta blocker treatment in 1 (1.5%).
Neither cryoballoon related-esophageal ulceration nor PV stenosis was
observed.
Conclusion: Gastroparesis, PNP and sinus tachycardia could be observed
in a significant number of cases after cryoballoon ablation of AF. These com-
plications are likely due to cryo-induced damages of nervous structures sur-
rounding the heart.
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Remote magnetic navigation in catheter ablation of persistent atrial
fibrillation
Mathieu Arnoult [Orateur], Decebal Gabriel Latcu, Philippe Ricard, Nadir
Saoudi
CH Princesse Grace, Monaco
Introduction: Efficacy of magnetic navigation for ablation of paroxysmal
atrial fibrillation (AF) has been shown. However data are sparse in patients
(pts) with persistent AF.
Aims: We report our experience using Magnetic Navigation System
(MNS) (Niobe, Stereotaxis) for catheter ablation of persistent AF.
Methods: Nineteen consecutive symptomatic pts (18 male, age 60,4±1,9 y)
with drug-resistant AF underwent ablation with an irrigated tip catheter, in
combination with a three dimensional electroanatomical mapping system
(Carto RMT). Ablation strategy consisted in wide area circumferential pulmo-
nary vein (PV) ablation with validation for electrical PV disconnection by a
circular mapping catheter, followed by complex fractionated atrial electro-
grams (CFAE) ablation, linear lesions and non PV foci ablation as required.
After discharge, pts were scheduled for repeated visits, ECGs and holter
recordings at 3 and 6 months (mth).
Results: AF history was 5,5 y and mean duration of the ongoing AF epi-
sode was 11 mth. Median left atrial (LA) size was 48,5 mm (28 cm2). All
pts underwent successful PV isolation, 74% linear lesions (LA roof line and/
or mitral isthmus line), 79% CFAE ablation and 28% non PV foci ablation.
Procedure duration was 215±50 min, fluoroscopy time 13±5 min (dose
849±534 mGy) and radiofrequency delivery duration 30±12 min. There was
no major complication. At 3 mth follow-up freedom from documented AF was
achievied in 35% of pts. After 1.8 procedures/pt and a median 6 mths follow-
up, 14 (73,7%) of 19 pts were in sinus rhythm.
Conclusions: Catheter ablation of persistent AF is effective and can be
safely performed using MNS. Efficacy is comparable to that reported with the
classic manual technique. Operator radioprotection and comfort are major
advantages in this type of lengthy procedure.
222
Predictive value of sleep apnea syndrome on efficacity of atrial
fibrillation ablation (3A study)
Naïma Zarqane [Orateur] , Michel Ange Cellario, Decebal Gabriel Latcu,
Céline Dugourd, Philippe Ricard, Nadir Saoudi
CH Princesse Grace, Cardiologie, Monaco
Background: The association of atrial fibrillation (AF) and sleep apnea
syndrome (SAS) is well established. The aim of this prospective study was
to estimate the relation between presence of SAS and outcome of first AF
ablation.
Methods and results: 49 patients (Pts) with symptomatic drug resistant
AF (71% paroxysmal) were included prospectively. All underwent clinical
evaluation, Berlin Questionnaire (BQ), transthoracic echocardiogram, and
overnight polygraphic study (OPS) before pulmonary vein isolation (with
possible lines/defragmentation in persistent forms). SAS were classified
according to the apnea-hypopnea index (AHI, significant if >15). Follow-
up consisted of 3 months(M) visits and 24 h Holter at M6. Pts with AHI
>15 underwent a new OPS at M6. Any episode of AF or flutter >30 sec-
ondes was considered a recurrence. OPS showed SAS in 12 pts (25%,
6 obstructive). Seventeen pts had a high risk by BQ (42,8%). In SAS
group, age (65,7 vs 60,7, p=0.01) body mass index (27,3 vs 25,5, p=0.04)
and LA diameter (45 vs 41 mm, p=0.019) were higher whereas ejection
fraction was lower (49% vs 63%, p=0.001). At M6, 29% of the SAS group
are AF free versus 78% in the other group. With multivariate analysis,
SAS was the only independent predictor of ablation failure (OR=7.33).
Conclusion: SAS was a powerful independent predictor for first AF abla-
tion failure.
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Prevalence of atrial fibrillation in an elderly contemporary French
cohort: the three city study-COVADIS
Guillaume Fleury [Orateur] (1), Nabila Haddour (1), Christophe Tzourio (2),
Cohen Ariel (1)
(1) AP-HP, CHU Saint-Antoine, Paris, France – (2) AP-HP, CHU La
Pitié-Salpêtrière, Paris, France
Background: Atrial fibrillation (AF) is a major public health concern
worldwide. Prior studies have established that key risk factors for the development
of AF include, age, hypertension, coronary artery disease (CAD), heart failure,
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